Sleep Apnea News and Research

RSS

ResMed announces acquisition of Laboratoires Narval

ResMed Inc. (NYSE: RMD), a leading developer, manufacturer and distributor of sleep and respiratory medical equipment, announced today that it has acquired Laboratoires Narval. Based in France, Laboratoires Narval manufactures and distributes the Narval O.R.M.(TM), an innovative mandibular repositioning device (MRD) that offers a solution to patients for snoring and obstructive sleep apnea (OSA), especially for those with mild OSA.

From ResMed Corp 6 Oct 2009

ImThera Medical launches the aura6000 neurostimulation system for treating Obstructive Sleep Apnea

Today, at the American Academy of Otolaryngology-Head and Neck Surgery annual meeting, ImThera Medical, Inc. unveiled its new product, the aura6000™ neurostimulation system for the treatment of Obstructive Sleep Apnea (OSA).

5 Oct 2009

Radiofrequency-tonsillotomy: Effective method for treating children with enlarged tonsils

Radiofrequncy-tonsillotomy, which enables surgeons to reduce the size of the tonsillar tissue instead of removing the tonsils entirely, seems to be an effective and safe method of treating children with symptoms of enlarged tonsils.

5 Oct 2009

GI tract conditions can occur in sleep apnea patients

Patients who suffer from obstructive sleep apnea (OSA) also tend to have additional gastrointestinal (GI) tract conditions, such as gastric reflux and hiatal hernia, which form at the opening in your diaphragm where your food pipe (esophagus) joins your stomach.

5 Oct 2009

Patients suffering from allergic rhinitis experience escalated symptoms of stress and fatigue

Patients who suffer from both allergic rhinitis and obstructive sleep apnea (OSA) may experience escalated symptoms of stress and fatigue.

5 Oct 2009

Radiofrequency ablation used to treat snoring patients

Radiofrequency ablation, a procedure that uses heat to shrink the tissue of the soft palate, is an effective and minimally invasive procedure that can be used to treat patients who snore.

5 Oct 2009

Imthera Medical receives Ethics Committee clearance to start human clinical trials in Belgium

ImThera Medical, Inc. has received Ethics Committee clearance to begin human clinical trials in Belgium. The trials will include ImThera’s Targeted Hypoglossal Neurostimulation (THN) Sleep Therapy to treat Obstructive Sleep Apnea (OSA). Along with the clinical trial approvals, ImThera has received ISO 13485 certification of its quality system as a pre-requisite for the future CE mark application for European commercialization of medical products.

1 Oct 2009

New treatment for chronic sinusitis from Summit Ear, Nose & Throat

Summit Ear, Nose & Throat is the first in the area to offer an exciting new treatment for chronic sinusitis (CRS) in an outpatient setting called FinESS™ Sinus Treatment. FinESS is a new balloon sinuplasty technique that is less invasive than traditional sinus surgery and that breaks the cycle of chronic sinusitis with immediate relief and lasting results.

30 Sep 2009

FDA grants priority review for Cephalon's sNDA

Cephalon, Inc. today announced the U.S. Food and Drug Administration (FDA) has granted a priority review for its supplemental New Drug Application (sNDA) for NUVIGIL(R) (armodafinil) Tablets [C-IV], which was filed in June of this year.

25 Sep 2009

ImThera Medical completes THN system development

ImThera Medical, Inc. announced today that it has completed development of its Targeted Hypoglossal Neurostimulation (THN) system for Obstructive Sleep Apnea (OSA).

24 Sep 2009

Ventus' PROVENT Sleep Apnea Therapy is runner-up at the The Wall Street Journal Technology Innovation Awards

Ventus Medical, a privately-held medical device company focused on improving the lives of patients with sleep-disordered breathing, today announced that the company's PROVENT(R) Sleep Apnea Therapy received the Runners-Up Award in The Wall Street Journal 2009 Technology Innovation Awards, Medical Devices category. The results were published in the September 14, 2009 edition of The Wall Street Journal.

22 Sep 2009

Mayo Clinic Health Letter discusses kidney stone treatment options

Ordinary, loud snoring doesn't seem to be harmful, according to the September issue of Mayo Clinic Health Letter. But snorers still may want to seek treatment to stop snoring, reduce embarrassment and improve sleep for themselves and their bed partner.

17 Sep 2009

Cardiac MRI exams gain prominence in the medical imaging market

Developments in imaging technology and software continue to help cardiac MRI exams gain prominence in the medical imaging market by meeting the demand for faster scan times and the ability to view areas of the body that were previously deemed impossible to image, according to "Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound" by healthcare market research firm Kalorama Information.

16 Sep 2009

Obesity experts call on policymakers to adopt obesity recommendations

The Obesity Society and other steering committee members of the Strategies to Overcome and Prevent (STOP) Obesity Alliance, and two former US Surgeons General, join together today to develop effective recommendations to urge policymakers to act on the inclusion of obesity as the largest and most urgent driving factor in healthcare reform.

10 Sep 2009

Authentidate to provide web-based healthcare documentation process to LifeCare Solutions

Authentidate Holding Corp. (Nasdaq: ADAT), a worldwide provider of secure Health Information Exchange and workflow management services, today announced that LifeCare Solutions, Inc., a leading Western U.S. provider of home healthcare services and medical equipment, selected Authentidate's Inscrybe(TM) Healthcare web-based service to simplify completion of healthcare documentation with physicians.

24 Aug 2009

Cortex Pharmaceuticals receives delisting notification from NYSE Amex

Cortex Pharmaceuticals, Inc. (NYSE Amex (COR)) reported that it has received a delisting notification from the NYSE Amex LLC indicating that it has not accepted the Company’s plan to regain compliance with the Exchange’s continued listing standards, as submitted by the Company in June.

21 Aug 2009

New website launched to determine sleep disorder

Nearly 20 million Americans suffer from sleep apnea, a serious health condition that has been linked to increased risks for obesity and weight gain, heart attack, stroke, high blood pressure, asthma and depression. Sleep apnea has also been cited by experts as the number one cause of car accidents. Ninety-five percent of sleep apnea cases go undiagnosed, putting the health of millions of Americans at risk.

21 Aug 2009

Surgeons of BMI of Texas selected to host a preceptorship for using REALIZE Adjustable Gastric Band

The Bariatric Medical Institute of Texas (“BMI of Texas”) today announced surgeons Mickey Seger and Terive Duperier have been selected by Ethicon Endo-Surgery, Inc. as one of the five training sites in the U.S. to host a preceptorship for the Ethicon Endo-Surgery REALIZE™ Adjustable Gastric Band.

20 Aug 2009

Sleep apnea increases chances of dying

Nightly bouts of interrupted, oxygen-deprived sleep from a collapsed airway in the upper neck raises the chances of dying in middle-aged to elderly people by as much as 46 percent in the most severe cases, according to a landmark study on sleep apnea by lung experts at Johns Hopkins and six other U.S. medical centers.

18 Aug 2009

Cognitive behavioral therapy improves sleep and pain in osteoarthritis

A study in the Aug. 15 issue of the Journal of Clinical Sleep Medicine shows that the use of cognitive behavioral therapy for insomnia (CBT-I) is an effective treatment for older patients with osteoarthritis and comorbid insomnia.

16 Aug 2009

Sleep Apnea News and Research

ResMed announces acquisition of Laboratoires Narval

ImThera Medical launches the aura6000 neurostimulation system for treating Obstructive Sleep Apnea

Radiofrequency-tonsillotomy: Effective method for treating children with enlarged tonsils

GI tract conditions can occur in sleep apnea patients

Patients suffering from allergic rhinitis experience escalated symptoms of stress and fatigue

Radiofrequency ablation used to treat snoring patients

Imthera Medical receives Ethics Committee clearance to start human clinical trials in Belgium

New treatment for chronic sinusitis from Summit Ear, Nose & Throat

FDA grants priority review for Cephalon's sNDA

ImThera Medical completes THN system development

Ventus' PROVENT Sleep Apnea Therapy is runner-up at the The Wall Street Journal Technology Innovation Awards

Mayo Clinic Health Letter discusses kidney stone treatment options

Cardiac MRI exams gain prominence in the medical imaging market

Obesity experts call on policymakers to adopt obesity recommendations

Authentidate to provide web-based healthcare documentation process to LifeCare Solutions

Cortex Pharmaceuticals receives delisting notification from NYSE Amex

New website launched to determine sleep disorder

Surgeons of BMI of Texas selected to host a preceptorship for using REALIZE Adjustable Gastric Band

Sleep apnea increases chances of dying

Cognitive behavioral therapy improves sleep and pain in osteoarthritis

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News